340 related articles for article (PubMed ID: 34479492)
21. Porphyromonas gingivalis lipopolysaccharide-induced macrophages modulate proliferation and invasion of head and neck cancer cell lines.
Utispan K; Pugdee K; Koontongkaew S
Biomed Pharmacother; 2018 May; 101():988-995. PubMed ID: 29635909
[TBL] [Abstract][Full Text] [Related]
22. M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB‑EGF.
Fu E; Liu T; Yu S; Chen X; Song L; Lou H; Ma F; Zhang S; Hussain S; Guo J; Sun J; Yu P; Mao X; Wei L
Oncol Rep; 2020 Aug; 44(2):698-710. PubMed ID: 32627036
[TBL] [Abstract][Full Text] [Related]
23. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
24. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
[TBL] [Abstract][Full Text] [Related]
25. The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
Ohashi T; Terasawa K; Aoki M; Akazawa T; Shibata H; Kuze B; Asano T; Kato H; Miyazaki T; Matsuo M; Inoue N; Ito Y
Auris Nasus Larynx; 2020 Aug; 47(4):658-667. PubMed ID: 32089351
[TBL] [Abstract][Full Text] [Related]
26. The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.
Boeckx C; Van den Bossche J; De Pauw I; Peeters M; Lardon F; Baay M; Wouters A
BMC Res Notes; 2015 Jun; 8():203. PubMed ID: 26032726
[TBL] [Abstract][Full Text] [Related]
27. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
28. Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages.
Wedekind H; Walz K; Buchbender M; Rieckmann T; Strasser E; Grottker F; Fietkau R; Frey B; Gaipl US; Rückert M
Strahlenther Onkol; 2022 Feb; 198(2):171-182. PubMed ID: 34665291
[TBL] [Abstract][Full Text] [Related]
29. Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
de la Iglesia JV; Slebos RJC; Martin-Gomez L; Wang X; Teer JK; Tan AC; Gerke TA; Aden-Buie G; van Veen T; Masannat J; Chaudhary R; Song F; Fournier M; Siegel EM; Schabath MB; Wadsworth JT; Caudell J; Harrison L; Wenig BM; Conejo-Garcia J; Hernandez-Prera JC; Chung CH
Clin Cancer Res; 2020 Mar; 26(6):1474-1485. PubMed ID: 31848186
[TBL] [Abstract][Full Text] [Related]
30. Expression and phosphorylation of Stathmin 1 indicate poor survival in head and neck squamous cell carcinoma and associate with immune suppression.
Wu H; Deng WW; Yang LL; Zhang WF; Sun ZJ
Biomark Med; 2018 Jul; 12(7):759-769. PubMed ID: 29847156
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
32. Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy.
Puntigam LK; Jeske SS; Götz M; Greiner J; Laban S; Theodoraki MN; Doescher J; Weissinger SE; Brunner C; Hoffmann TK; Schuler PJ
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707816
[TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms.
Wang G; Zhang M; Cheng M; Wang X; Li K; Chen J; Chen Z; Chen S; Chen J; Xiong G; Xu X; Wang C; Chen D
Cancer Lett; 2021 Jun; 507():55-69. PubMed ID: 33741424
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer cell supernatants induce a phenotypic switch from U937-derived macrophage-activated M1 state into M2-like suppressor phenotype with change in Toll-like receptor profile.
Sánchez-Reyes K; Bravo-Cuellar A; Hernández-Flores G; Lerma-Díaz JM; Jave-Suárez LF; Gómez-Lomelí P; de Celis R; Aguilar-Lemarroy A; Domínguez-Rodríguez JR; Ortiz-Lazareno PC
Biomed Res Int; 2014; 2014():683068. PubMed ID: 25309919
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy for Head and Neck Cancer.
Sim F; Leidner R; Bell RB
Hematol Oncol Clin North Am; 2019 Apr; 33(2):301-321. PubMed ID: 30833002
[TBL] [Abstract][Full Text] [Related]
36. Macrophage Polarization States in the Tumor Microenvironment.
Boutilier AJ; Elsawa SF
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
[TBL] [Abstract][Full Text] [Related]
37. Role of Toll-like receptor 9 in Legionella pneumophila-induced interleukin-12 p40 production in bone marrow-derived dendritic cells and macrophages from permissive and nonpermissive mice.
Newton CA; Perkins I; Widen RH; Friedman H; Klein TW
Infect Immun; 2007 Jan; 75(1):146-51. PubMed ID: 17060467
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages.
Deshmukh SK; Tyagi N; Khan MA; Srivastava SK; Al-Ghadhban A; Dugger K; Carter JE; Singh S; Singh AP
Sci Rep; 2018 Aug; 8(1):12000. PubMed ID: 30097594
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte mitochondrial DNA mediates macrophage immune response in liver injury induced by trichloroethylene.
Gao L; Zuo XL; Dong LL; Zhou SF; Wang ZJ; Duan YS; Chen MY; Zhu QX; Zhang JX
Ecotoxicol Environ Saf; 2024 May; 276():116317. PubMed ID: 38615641
[TBL] [Abstract][Full Text] [Related]
40. Endoplasmic reticulum stress promotes the release of exosomal PD-L1 from head and neck cancer cells and facilitates M2 macrophage polarization.
Yuan Y; Jiao P; Wang Z; Chen M; Du H; Xu L; Xu J; Dai Y; Wu FG; Zhang Y; Wu H
Cell Commun Signal; 2022 Jan; 20(1):12. PubMed ID: 35090495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
